Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRIM24 | O15164 | 1/20 | 0.41 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | MGLL | Q99685 | 2/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.36 |
| ▸ | BAD | Q92934 | 1/20 | 0.36 |
| ▸ | KMO | O15229 | 1/20 | 0.35 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27286718 | 0.80 | ALDH1A1 (0.44) | ALDH1A1MGLLATMCA1BCL2L1 | |
| SCHEMBL8904307 | 0.80 | ENPP2 (0.54) | TRIM24TRIM33ALDH1A1MAOABCL2L1 | |
| SCHEMBL8904305 | 0.80 | ENPP2 (0.54) | TRIM24TRIM33ALDH1A1MAOABCL2L1 | |
| SCHEMBL224946 | 0.79 | — | — | |
| SCHEMBL14876890 | 0.79 | TRIM24 (0.41) | TRIM24TRIM33ALDH1A1MGLLMAOA | |
| SCHEMBL11153461 | 0.77 | TLR4 (0.54) | HSP90AA1PKMHTTKDM4ETP53 | |
| SCHEMBL2843934 | 0.75 | MAOA (0.48) | TRIM24TRIM33ALDH1A1MGLLMAOA | |
| SCHEMBL10544818 | 0.75 | CALM1 (0.44) | ALDH1A1MAOAATMBCL2L1PRSS1 | |
| SCHEMBL10547540 | 0.75 | MAOA (0.49) | ALDH1A1MAOAHDAC4HDAC2HDAC8 | |
| SCHEMBL11065825 | 0.75 | MAPT (0.54) | ALDH1A1HTTKDM4EPTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140294968-A1 | POLYACRYLATE-BASED ACTIVE COMPOUND-COMPRISING PARTICLES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-10-02 | — | — | US | disclosed |
| EP-2736326-A1 | POLYACRYLATE-BASED ACTIVE COMPOUND-COMPRISING PARTICLES | Bayer Intellectual Property GmbH (DE) | 2014-06-04 | — | — | EP | disclosed |
| WO-2013014127-A1 | POLYACRYLATE-BASED ACTIVE COMPOUND-COMPRISING PARTICLES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-01-31 | — | — | WO | disclosed |
| US-8097603-B2 | Compositions for controlling parasites on animals | BAYER ANIMAL HEALTH GMBH (DE) | 2012-01-17 | — | — | US | disclosed |
| US-20070259834-A1 | Dermally Applicable Liquid Formulations for Controlling Parasitic Arthropods on Animals | BAYER HEALTH CARE AG (DE) | 2007-11-08 | — | — | US | disclosed |
| US-20060252728-A1 | Compositions for controlling parasites on animals | BAYER HEALTHCARE AG (DE) | 2006-11-09 | — | — | US | disclosed |
| US-20060111323-A1 | Use of polysiloxanes having quaternary ammonium groups as formulation auxiliaries, and compositions comprising them | BAYER ANIMAL HEALTH GMBH (DE) | 2006-05-25 | — | — | US | disclosed |
| US-7025978-B1 | Use of polysiloxanes containing quarternary amino groups as formulation auxiliary agents, and agents containing the same | BAYER AG (DE) | 2006-04-11 | — | — | US | disclosed |
| EP-1241943-B1 | USE OF POLYSILOXANES CONTAINING QUATERNARY AMINO GROUPS AS FORMULATION AUXILIARY AGENTS, AND AGENTS CONTAINING THE SAME | BAYER HEALTHCARE AG (DE) | 2005-03-02 | — | — | EP | disclosed |
| EP-1241943-A1 | USE OF POLYSILOXANES CONTAINING QUATERNARY AMINO GROUPS AS FORMULATION AUXILIARY AGENTS, AND AGENTS CONTAINING THE SAME | Bayer Aktiengesellschaft (DE) | 2002-09-25 | — | — | EP | disclosed |
| WO-2001035739-A1 | USE OF POLYSILOXANES CONTAINING QUATERNARY AMINO GROUPS AS FORMULATION AUXILIARY AGENTS, AND AGENTS CONTAINING THE SAME | BAYER AKTIENGESELLSCHAFT (DE) | 2001-05-25 | — | — | WO | disclosed |
| CN-1140016-A | Pesticidal composition | CIBA GEIGY AG (CH) | 1997-01-15 | — | — | CN | disclosed |
| EP-0160182-B1 | INSECTICIDAL AQUEOUS-BASED MICRO EMULSION COMPOSITIONS | AMERICAN CYANAMID COMPANY (US) | 1993-03-03 | — | — | EP | disclosed |
| US-4904695-A | BLEND WITH SURFACTANT, ANTIFOAM AGENT, THICKENERS, ANTIFREEZE AGENT AND PRESERVATIVE | AMERICAN CYANAMID COMPANY (US) | 1990-02-27 | — | — | US | disclosed |
| EP-0160182-A2 | Insecticidal aqueous-based micro emulsion compositions | AMERICAN CYANAMID COMPANY (US) | 1985-11-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070259834-A1 | Dermally Applicable Liquid Formulations for Controlling Parasitic Arthropods on Animals | CUTA, DDT, TYR | TRIM24 3124/4885TRIM33 2413/4885ALDH1A1 2598/4885 |
| US-20060252728-A1 | Compositions for controlling parasites on animals | MELK, DEK, CUTA | TRIM24 2582/4885TRIM33 1289/4885ALDH1A1 4814/4885 |
| US-20140294968-A1 | POLYACRYLATE-BASED ACTIVE COMPOUND-COMPRISING PARTICLES | PLOD3, CUTA, NUP205 | TRIM24 715/4885TRIM33 370/4885ALDH1A1 822/4885 |
| US-20060111323-A1 | Use of polysiloxanes having quaternary ammonium groups as formulation auxiliaries, and compositions comprising them | PIGS, PSMD9, PSMC2 | TRIM24 2288/4885TRIM33 706/4885ALDH1A1 3218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.